FDA Releases Guidance on ‘Fit-for-Purpose’ Clinical Outcome Assessments

In its latest guidance on patient-focused drug development, released yesterday, the FDA calls for high-quality clinical outcome assessments (COAs) for drug trials.
Source: Drug Industry Daily